Media Database
>
Doug Brunk

Doug Brunk

Reporter at MDedge

Contact this person
Email address
d*****@*******.comGet email address
Influence score
56
Location
United States
Languages
  • English
Covering topics
  • Public Relations

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

mdedge.com

What does the future of psoriasis treatment look like? - MDedge

“We have terrific drugs for psoriasis, but how can we do better?” Dr. Andrew Blauvelt asked.
mdedge.com

Treating rosacea: Combination therapy, benzoyl peroxide, and the ‘S...

Treating rosacea: Combination therapy, benzoyl peroxide, and the ‘STOP’ mnemonic
mdedge.com

Treating rosacea: Combination therapy, benzoyl peroxide, and the ‘S...

Treating rosacea: Combination therapy, benzoyl peroxide, and the ‘STOP’ mnemonic
mdedge.com

Spinosad: New kid on the block for treating scabies

Spinosad: New kid on the block for treating scabies
mdedge.com

Indian Health Service dermatologist: ‘I saw a real need to be of se...

In 2017, Dr. Christopher Bengson was appointed as the IHS’s first chief clinical consultant for dermatology, a post that provides him the opportunity to interface with Native people and IHS-affiliated clinicians nationwide.
mdedge.com

Study highlights diagnostic challenges of differentiating lichen .....

The investigators aimed to characterize differences in LS and vitiligo based on history, physical exam, and demographic findings at the initial clinic visit.
mdedge.com

Analysis reveals recent acne prescribing trends - MDedge

The study period covered a mean of 1.9 million acne encounters per year.
mdedge.com

EMA validates marketing authorization application for delgocitinib ...

Delgocitinib is being evaluated for the treatment of chronic hand eczema in adults.
mdedge.com

Mohs found to confer survival benefit in localized Merkel cell ... ...

Results provide “preliminary data suggesting that treatment of localized, early-stage MCC with MMS may result in the most optimal patient survival outcomes,” the authors wrote.
mdedge.com

Treatment options for vitiligo reviewed

Treatment options for vitiligo reviewed
mdedge.com

Systematic review spotlights the use of nutraceuticals for acne

Systematic review spotlights the use of nutraceuticals for acne
mdedge.com

Autoimmune Skin Diseases Linked To Risk Of Adverse Pregnancy Outcom...

The three most common autoimmune skin diseases in the study cohort were vitiligo (30%), alopecia areata (30%), and cutaneous lupus erythematosus (27%).
mdedge.com

MDedge - MDedge

MDedge - MDedge
mdedge.com

Study Eyes Longer IV Ertapenem for Recalcitrant Hidradenitis Suppur...

The mean treatment duration was 13.1 weeks and the mean posttherapy follow-up occurred after a mean of 7.8 weeks.
mdedge.com

Formulation of Sclerotherapy Agent Found Useful for Submental Fat R...

The intent-to-treat population included 51 subjects at four sites.
mdedge.com

What Does Health Equity in Dermatology Look Like? - MDedge

“If you are contributing to cases in textbooks, make sure you have a variety of different skin types so that individuals who are referring to the textbooks will be more equipped,” Dr. Patricia A. Treadwell advised.
mdedge.com

Is A Patient Getting Under Your Skin? A Dermatologist Shares Tips f...

Sometimes it’s best to resign from providing care to difficult patients, Dr. Jason Reichenberg said.
mdedge.com

New Tool Helps Clinicians Detect Zoom Dysmorphia in Virtual Setting...

Affected individuals may fear being misunderstood, judged, or ridiculed because of a perceived flaw in their appearance, Dr. George Kroumpouzos said.
mdedge.com

Expert Highlights Emerging Trends in Neuromodulators - MDedge

One potential newcomer is ready-to-use liquid botulinum neurotoxin, which contains no human or animal-derived excipients.
mdedge.com

CDC Investigating Adverse Events Related to Counterfeit, Mishandled...

Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism.
mdedge.com

Support for Laser Treatment to Reduce NMSC Risk is Increasing

Support for Laser Treatment to Reduce NMSC Risk is Increasing